• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性5-羟色胺再摄取抑制剂

Selective Serotonin Reuptake Inhibitors.

作者信息

Lochmann Dee, Richardson Tara

机构信息

Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USA.

出版信息

Handb Exp Pharmacol. 2019;250:135-144. doi: 10.1007/164_2018_172.

DOI:10.1007/164_2018_172
PMID:30838457
Abstract

The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects. In this way, SSRIs were created to be safer and more tolerable than previous antidepressants. SSRIs share many similarities, but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.

摘要

第一代抗抑郁药是偶然发现的,但由此产生了一种观点,即中枢5-羟色胺激动作用可产生抗抑郁效果。选择性5-羟色胺再摄取抑制剂(SSRI)是首批经过合理设计的精神药物,这意味着研究人员旨在利用特定的作用机制,同时避免不良反应。通过这种方式,SSRI被设计得比以往的抗抑郁药更安全、更易耐受。SSRI有许多相似之处,但在药代动力学和对细胞色素P450酶的影响方面存在差异,本章将对此进行详细阐述。还将提供有关安全性、临床适应症/用途和给药建议的更多信息。

相似文献

1
Selective Serotonin Reuptake Inhibitors.选择性5-羟色胺再摄取抑制剂
Handb Exp Pharmacol. 2019;250:135-144. doi: 10.1007/164_2018_172.
2
Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.选择性5-羟色胺再摄取抑制剂的临床相关药理学。重点关注药代动力学及对药物氧化代谢影响的综述。
Clin Pharmacokinet. 1997;32 Suppl 1:1-21. doi: 10.2165/00003088-199700321-00003.
3
Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的药代动力学-药效学关系
Clin Pharmacokinet. 1996 Dec;31(6):444-69. doi: 10.2165/00003088-199631060-00004.
4
Other Antidepressants.其他抗抑郁药。
Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167.
5
Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.新型抗抑郁药与σ-1受体伴侣的相互作用及其对PC12细胞神经突生长的促进作用。
Eur J Pharmacol. 2014 Mar 15;727:167-73. doi: 10.1016/j.ejphar.2014.01.064. Epub 2014 Feb 5.
6
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.低压缺氧暴露会使选择性 5-羟色胺再摄取抑制剂氟西汀、帕罗西汀、艾司西酞普兰和舍曲林对大鼠的抗抑郁作用产生差异。
Pharmacol Biochem Behav. 2018 Jul;170:25-35. doi: 10.1016/j.pbb.2018.05.002. Epub 2018 May 5.
7
The pharmacogenetics of the selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的药物遗传学
Clin Investig. 1993 Dec;71(12):1002-9. doi: 10.1007/BF00180032.
8
[The transfer of selective serotonin reuptake inhibitors to human milk].[选择性5-羟色胺再摄取抑制剂向母乳中的转移]
Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):199-203.
9
Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.情感障碍中的选择性5-羟色胺再摄取抑制剂——I. 基础药理学
J Psychopharmacol. 1998;12(3 Suppl B):S5-20. doi: 10.1177/0269881198012003021.
10
Care of depression in the elderly: comparative pharmacokinetics of SSRIs.老年人抑郁症的治疗:选择性5-羟色胺再摄取抑制剂的比较药代动力学
Int Clin Psychopharmacol. 1998 Sep;13 Suppl 5:S35-43. doi: 10.1097/00004850-199809005-00008.

引用本文的文献

1
The Role of the 5-HTTLPR Gene Variation of the SLC6A4 Serotonergic System in the Development of Addictive Disorders: A Narrative Review.SLC6A4血清素系统的5-HTTLPR基因变异在成瘾性障碍发展中的作用:一项叙述性综述。
Consort Psychiatr. 2025 Jun 23;6(2):65-75. doi: 10.17816/CP15611. eCollection 2025.
2
Association of antidepressant use during pregnancy and pregnancy-induced hypertension: a systematic review and meta-analysis.孕期使用抗抑郁药与妊娠期高血压的关联:一项系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2025 Aug 25;25(1):884. doi: 10.1186/s12884-025-07974-6.
3
Fluoxetine substitution for deprescribing antidepressants: a technical approach.
用氟西汀替代减停抗抑郁药:一种技术方法。
J Psychiatry Neurosci. 2025 Jul 3;50(4):E202-E209. doi: 10.1503/jpn.250054. Print 2025 Jul-Aug.
4
Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome.抗抑郁药物的进展:药物发现与基于聚合物的药物递送系统以改善治疗效果。
Biomedicines. 2025 Apr 29;13(5):1081. doi: 10.3390/biomedicines13051081.
5
Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and Analyses.通过结合计算系统生物学与分析揭示选择性5-羟色胺再摄取抑制剂在前列腺癌中的抗癌潜力
ACS Omega. 2025 Apr 8;10(15):15204-15218. doi: 10.1021/acsomega.4c10939. eCollection 2025 Apr 22.
6
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening.美国向医疗补助计划和医疗保险患者开具(艾司)西酞普兰处方的模式:药品再注册的潜在影响。
Front Psychiatry. 2025 Mar 5;16:1450111. doi: 10.3389/fpsyt.2025.1450111. eCollection 2025.
7
Trends in research on novel antidepressant treatments.新型抗抑郁治疗的研究趋势。
Front Pharmacol. 2025 Jan 27;16:1544795. doi: 10.3389/fphar.2025.1544795. eCollection 2025.
8
Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action.选择性5-羟色胺再摄取抑制剂:对ESKAPEE细菌的抗菌活性及作用机制
Antibiotics (Basel). 2025 Jan 8;14(1):51. doi: 10.3390/antibiotics14010051.
9
Mechanism of Banxia Houpo Decoction in Treating Gastroesophageal Reflux Disease: An Integrated Approach of Compound Analysis, Network Pharmacology and Empirical Verification.半夏厚朴汤治疗胃食管反流病的机制:基于成分分析、网络药理学和实验验证的综合方法
Chin J Integr Med. 2025 Jan 14. doi: 10.1007/s11655-025-3825-x.
10
Effect of serotonin receptor gene variants on substance use disorders.血清素受体基因变异对物质使用障碍的影响。
Ann Med. 2025 Dec;57(1):2445779. doi: 10.1080/07853890.2024.2445779. Epub 2024 Dec 28.